LabCompass

Kirti Kaul

Medicine · The Ohio State University

OpenAlex
Mid career · publishing since 2010
Retinal Diseases and TreatmentsPancreatic function and diabetesRetinal Imaging and AnalysisLiver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Publications

39

Citations

3,046

Est. group size

~5

Recurring co-author estimate

Active years

15

Publishing since 2010

Research summary
AI-generated

Kirti Kaul's research focuses on diabetes and its metabolic complications, including how gut microbiota, liver fat, and oxidative metabolism relate to insulin resistance and nerve damage (polyneuropathy) in diabetes. Work spans laboratory studies in mouse models as well as investigations of human patients with type 1 diabetes and fatty liver disease, often published in general diabetes and biochemistry journals.

Diabetes and insulin resistanceGut microbiota and metabolic diseaseNonalcoholic fatty liver diseaseOxidative stress and metabolismDiabetic complications (e.g., polyneuropathy)

Publication output rose from 2017 to a peak around 2021-2022, then dropped sharply with little to no output reported in 2023 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 2 publications172018: 2 publications182019: 4 publications192020: 3 publications202021: 5 publications212022: 6 publications622232024: 2 publications242526
Recent publications
Publishes in
  • Cancer Research×7
  • Diabetes×2
  • Journal of Biological Chemistry×2
  • Oncogene×1
  • Cell Death and Disease×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile